Targeting Cancer Stem Cells as the Key Driver of Carcinogenesis and Therapeutic Resistance DOI Open Access
Refaat A. Eid, Muhammad Alaa Eldeen,

Eslam M. Shedid

et al.

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(2), P. 1786 - 1786

Published: Jan. 16, 2023

The emerging concept of cancer stem cells (CSCs) as the key driver behind carcinogenesis, progression, and diversity has displaced prior model a tumor composed with similar subsequently acquired mutations an equivalent capacity for renewal, invasion, metastasis. This significant change shifted research focus toward targeting CSCs to eradicate cancer. may be characterized using cell surface markers. They are defined by their self-renew differentiate, resist conventional therapies, generate new tumors following repeated transplantation in xenografted mice. CSCs' functional capabilities governed various intracellular extracellular variables such pluripotency-related transcription factors, internal signaling pathways, external stimuli. Numerous natural compounds synthetic chemicals have been investigated ability disrupt these regulatory components inhibit stemness terminal differentiation CSCs, hence achieving clinical implications. However, no treatment focuses on biological consequences drugs functions established. article provides biomedical discussion at time along overview origin, features, characterization, isolation techniques, novel targeted therapeutic approaches. Additionally, we highlighted factors endorsed controlling or helping promote CSCs. Our objective was encourage future studies prospective treatments develop framework application single combined therapeutics forms

Language: Английский

Recent Progress in the Theranostics Application of Nanomedicine in Lung Cancer DOI Open Access
Anubhab Mukherjee, Manash K. Paul, Sudip Mukherjee

et al.

Cancers, Journal Year: 2019, Volume and Issue: 11(5), P. 597 - 597

Published: April 29, 2019

Lung cancer is one of the leading causes cancer-related death worldwide. Non-small cell lung (NSCLC) around 80% to 90% deaths. The lack an early diagnosis and inefficiency in conventional therapies poor prognosis overall survival patients. Recent progress nanomedicine has encouraged development alternative theranostics strategy using nanotechnology. interesting physico-chemical properties nanoscale have generated immense advantages for nanoparticulate systems detection active delivery drugs a better cancer. This present review provides detailed overview recent application nanoparticles including liposomes, polymeric, metal bio-nanoparticles. Further, we summarize disadvantages each approach considering improvement theranostics.

Language: Английский

Citations

111

Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells DOI Creative Commons
Yu Yi, Hyun Jin Kim, Meng Zheng

et al.

Journal of Controlled Release, Journal Year: 2019, Volume and Issue: 295, P. 268 - 277

Published: Jan. 9, 2019

Language: Английский

Citations

109

Nanoparticles for imaging and treatment of metastatic breast cancer DOI
Qingxin Mu, Hui Wang, Miqin Zhang

et al.

Expert Opinion on Drug Delivery, Journal Year: 2016, Volume and Issue: 14(1), P. 123 - 136

Published: July 12, 2016

Metastatic breast cancer is one of the most devastating cancers that have no cure. Many therapeutic and diagnostic strategies been extensively studied in past decade. Among these strategies, nanotechnology has emerged as a promising strategy preclinical studies by enabling early identification primary tumors metastases, effective killing cells. Areas covered: This review covers recent progress made targeting imaging metastatic with nanoparticles, treatment using nanoparticle-enabled chemo-, gene, photothermal- radio-therapies. also discusses developments stem cell therapy immunotherapy. Expert opinion: Nanotechnology expected to play important roles modern for cancers, including cancer. Nanoparticles are able target visualize metastasis various organs, deliver agents. Through cells, nanoparticles treat resistant minimal toxicity healthy tissues/organs. activate immune cells eliminate tumors. Owing their multifunctional, controllable trackable features, nanotechnology-based could be highly potent approach future research treatment.

Language: Английский

Citations

107

Nanoparticle-facilitated autophagy inhibition promotes the efficacy of chemotherapeutics against breast cancer stem cells DOI
Rong Sun, Song Shen, Yunjiao Zhang

et al.

Biomaterials, Journal Year: 2016, Volume and Issue: 103, P. 44 - 55

Published: June 27, 2016

Language: Английский

Citations

107

Targeted destruction of cancer stem cells using multifunctional magnetic nanoparticles that enable combined hyperthermia and chemotherapy DOI Creative Commons
Dandan Liu, Yingcai Hong, Yaping Li

et al.

Theranostics, Journal Year: 2020, Volume and Issue: 10(3), P. 1181 - 1196

Published: Jan. 1, 2020

Cancer stem cells (CSCs) have been implicated in cancer recurrence and therapy resistance. Therefore, a CSC-targeted that disrupts the maintenance survival of CSCs may offer an effective approach killing tumor primary tumors preventing metastasis caused by CSCs. Nanoparticles (NPs)-based thermotherapy and/or chemotherapy are promising therapeutic methods for treatment. Methods: A silica-based multifunctional NP system was present, which encapsulated chemotherapeutic agent magnetic cores coated with specific antibody against lung The efficacy this novel strategy systematically studied both vitro vivo simultaneous activating combined via NPs. Results: These NPs were administered activated targeted using externally applied alternating field (AMF). antibody-modified to enhanced cellular uptake extended accumulation vivo. Up 98% killed 30-min application AMF, due effects hyperthermia drug In models, significantly suppressed growth CSC xenograft-bearing mice, minimal side adverse effects. Conclusion: With good biocompatibility targeting capability, nanodrug delivery clinical platform chemotherapy. This work demonstrated feasibility developing nanomedicine

Language: Английский

Citations

105

Transforming nanomedicine manufacturing toward Quality by Design and microfluidics DOI
Stefano Colombo, Moritz Beck‐Broichsitter,

Johan Bøtker

et al.

Advanced Drug Delivery Reviews, Journal Year: 2018, Volume and Issue: 128, P. 115 - 131

Published: March 1, 2018

Language: Английский

Citations

102

Nucleus-targeted nano delivery system eradicates cancer stem cells by combined thermotherapy and hypoxia-activated chemotherapy DOI
Hongjuan Li, Weixiao Yan,

Xiaomin Suo

et al.

Biomaterials, Journal Year: 2019, Volume and Issue: 200, P. 1 - 14

Published: Feb. 9, 2019

Language: Английский

Citations

102

The reversal of chemotherapy-induced multidrug resistance by nanomedicine for cancer therapy DOI

Shangui Liu,

Abdur Rauf Khan, Xiaoye Yang

et al.

Journal of Controlled Release, Journal Year: 2021, Volume and Issue: 335, P. 1 - 20

Published: May 12, 2021

Language: Английский

Citations

96

An efficient antimicrobial depot for infectious site-targeted chemo-photothermal therapy DOI Creative Commons
Menglong Liu,

Danfeng He,

Tao Yang

et al.

Journal of Nanobiotechnology, Journal Year: 2018, Volume and Issue: 16(1)

Published: March 16, 2018

Silver and photothermal therapy (PTT) have been widely used for eradicating the drug-resistant bacteria. However, risks of excess silver humans low efficiency PTT still limit their in vivo therapeutic application. Integration two distinctive bactericides into one entity is a promising platform to improve antimicrobial agents.In this study, chemo-photothermal based on polydopamine (PDA)-coated gold nanorods (GNRs) was developed. The PDA coating acquired high Ag+ ions loading Cy5-SE fluorescent agent labeled glycol chitosan (GCS) conjugation (Ag+-GCS-PDA@GNRs). This became positively charged pH environment abscess, allowing accumulation local infection site as revealed by thermal/florescence imaging. loaded released pH-sensitive manner, resulting selective delivery abscess (pH ~ 6.3). More importantly, ultralow dose could effectively damage bacterial membrane, causing permeability increase heat resistance reduction cell leading large improvement bactericidal PTT. On other hand, hyperthermia trigger more release, further chemotherapy. Combinational chemo-hyperthermia Ag+-GCS-PDA@GNRs thoroughly ablate accelerate wound healing via synergistic antibacterial effect.Our studies demonstrate that robust practical use chemo-thermal focal with outstanding bacteria ablating.

Language: Английский

Citations

95

Combined cancer therapy with hyaluronan-decorated fullerene-silica multifunctional nanoparticles to target cancer stem-like cells DOI
Hai Wang, Pranay Agarwal, Shuting Zhao

et al.

Biomaterials, Journal Year: 2016, Volume and Issue: 97, P. 62 - 73

Published: May 7, 2016

Language: Английский

Citations

94